ELIMCV Trademark

Medicines for human purposes for the treatment of disease of respiratory system, acute respiratory distress syndrome, ANCA-associated vasculitis, Corona Virus Disease 2019, autoimmune disorders, inflammatory response syndrome (SIRS), sepsis, septic shock, ischemia/reperfusion related injuries, acute lung injury, pneumonia, acute and chronic graft rejection in transplant patients, graft versus host reactions, renal glomerular diseases, glomerulonephritis, entities of renal failure, rheumatoid arthritis, auto-immune diseases, Bechterew's disease, lupus-type diseases, inflammatory bowel disease, Crohn's disease, tumor growth, and solid organ cancer; pharmaceutical preparations for the treatment of disease of respiratory system; Diagnostic preparations for medical purposes; dietetic foods and beverages adapted for medical use; depuratives for the body; veterinary pharmaceutical compounds for the treatment of respiratory system disease; Pesticides; first aid kits; Dental abrasives